Literature DB >> 29101672

Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis.

José Antonio De Jesús Batún-Garrido1, Marisol Salas-Magaña2, Isela Esther Juárez-Rojop2.   

Abstract

Pro-inflammatory cytokines such as leptin and IL-6 play an important role in the development of cardiovascular risk. Determine the relationship between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis. We determined IL-6 and leptin levels in 77 patients with the diagnosis of rheumatoid arthritis. The cardiovascular risk was calculated using the modified Framingham scale. Statistical analysis was performed using SPSS 22 considering a significant p < 0.05. Serum leptin concentrations and cardiovascular risk (CVR) factors were compared and found that there was a significant difference between higher leptin values and disease activity (p 0.047), obesity (p 0.038), positive rheumatoid factor (p 0.009), tobacco (p 0.009), and metabolic syndrome (p 0.001). Likewise, a significant relationship was found between lower leptin concentrations and hydroxychloroquine consumption (p = 0.023). We found significant difference between IL-6 concentrations and disease activity (p 0.028), hypertriglyceridemia (p 0.023), LDL-C (p 0.029), and smoking (0.005). Similarly, an association between hydroxychloroquine consumption and low concentrations of IL-6 was found (p 0.005). Framingham CVR was calculated and the result obtained was multiplied by 1.5. The 35.2% of the population studied had a low Framingham CVR, 38.9% moderate, and 25.9% presented a high risk. We compared the level of CVR and serum leptin and IL-6 concentrations, finding that the highest CVR was the leptin and IL-6 values. There is a positive association between CVR and serum leptin concentrations. It is also significantly associated with traditional and non-traditional risk factors.

Entities:  

Keywords:  Cardiovascular risk; Leptin; Metabolic syndrome; Rheumatoid arthritis

Mesh:

Substances:

Year:  2017        PMID: 29101672     DOI: 10.1007/s10067-017-3897-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

Review 1.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

2.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

3.  Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.

Authors:  C-H Jang; J-H Choi; M-S Byun; D-M Jue
Journal:  Rheumatology (Oxford)       Date:  2006-01-17       Impact factor: 7.580

4.  Serum leptin levels do not correlate with disease activity in rheumatoid arthritis.

Authors:  Sibel Yilmaz Oner; Omur Volkan; Can Oner; Alperen Mengi; Haner Direskeneli; Demet Ataman Tasan
Journal:  Acta Reumatol Port       Date:  2015 Jan-Mar       Impact factor: 1.290

5.  Leptin and Inflammation.

Authors:  Noriko Iikuni; Queenie Lai Kwan Lam; Liwei Lu; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Immunol Rev       Date:  2008-05-01

6.  Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis.

Authors:  Bozena Targońska-Stepniak; Magdalena Dryglewska; Maria Majdan
Journal:  Rheumatol Int       Date:  2009-07-12       Impact factor: 2.631

7.  Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.

Authors:  Inga-Lill Engvall; Birgitta Tengstrand; Kerstin Brismar; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2010-10-21       Impact factor: 5.156

8.  Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity.

Authors:  Gina B Di Gregorio; Lori Hensley; Tong Lu; Gouri Ranganathan; Philip A Kern
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07       Impact factor: 4.310

Review 9.  Atherosclerosis in rheumatoid arthritis: is it all about inflammation?

Authors:  Sarah Skeoch; Ian N Bruce
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

Review 10.  Cardiovascular disease in autoimmune rheumatic diseases.

Authors:  Ivana Hollan; Pier Luigi Meroni; Joseph M Ahearn; J W Cohen Tervaert; Sam Curran; Carl S Goodyear; Knut A Hestad; Bashar Kahaleh; Marcello Riggio; Kelly Shields; Mary C Wasko
Journal:  Autoimmun Rev       Date:  2013-03-27       Impact factor: 9.754

View more
  12 in total

1.  Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis.

Authors:  Gabriel-Santiago Rodríguez-Vargas; Pedro Santos-Moreno; Jaime-Andrés Rubio-Rubio; Paula-Katherine Bautista-Niño; Darío Echeverri; Luz-Dary Gutiérrez-Castañeda; Fabio Sierra-Matamoros; Stephania Navarrete; Anggie Aparicio; Luis Saenz; Adriana Rojas-Villarraga
Journal:  Front Cardiovasc Med       Date:  2022-07-05

Review 2.  Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.

Authors:  Federico Carbone; Aldo Bonaventura; Luca Liberale; Sabrina Paolino; Francesco Torre; Franco Dallegri; Fabrizio Montecucco; Maurizio Cutolo
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

3.  Therapeutic Effects of Naringin in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation.

Authors:  Yirixiati Aihaiti; Yong Song Cai; Xiadiye Tuerhong; Yan Ni Yang; Yao Ma; Hai Shi Zheng; Ke Xu; Peng Xu
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

Review 4.  Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication.

Authors:  Gashaw Dessie; Birhanu Ayelign; Yonas Akalu; Tewodros Shibabaw; Meseret Derbew Molla
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-17       Impact factor: 3.168

Review 5.  The Adipokine Network in Rheumatic Joint Diseases.

Authors:  Mar Carrión; Klaus W Frommer; Selene Pérez-García; Ulf Müller-Ladner; Rosa P Gomariz; Elena Neumann
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

Review 6.  Interleukin-6 in Rheumatoid Arthritis.

Authors:  Franco Pandolfi; Laura Franza; Valentina Carusi; Simona Altamura; Gloria Andriollo; Eleonora Nucera
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

Review 7.  Adipokines and Autoimmunity in Inflammatory Arthritis.

Authors:  Elena Neumann; Rebecca Hasseli; Selina Ohl; Uwe Lange; Klaus W Frommer; Ulf Müller-Ladner
Journal:  Cells       Date:  2021-01-22       Impact factor: 6.600

Review 8.  Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

Authors:  Priyanka Pahan; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-15       Impact factor: 4.147

9.  Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.

Authors:  Immacolata Faraone; Fabiana Labanca; Maria Ponticelli; Nunziatina De Tommasi; Luigi Milella
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

Review 10.  Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.

Authors:  Lucia Recinella; Giustino Orlando; Claudio Ferrante; Annalisa Chiavaroli; Luigi Brunetti; Sheila Leone
Journal:  Front Physiol       Date:  2020-10-30       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.